AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smolin, L. A.
Right arrow Articles by Benevenga, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smolin, L. A.
Right arrow Articles by Benevenga, N. J.
Agricola
Right arrow Articles by Smolin, L. A.
Right arrow Articles by Benevenga, N. J.

American Journal of Clinical Nutrition, Vol 39, 730-737, Copyright © 1984 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

The use of cyst(e)ine in the removal of protein-bound homocysteine

LA Smolin and NJ Benevenga

Competition between homocyst(e)ine and cyst(e)ine for binding sites on plasma proteins was examined both in vivo and in vitro. Plasma-free cyst(e)ine concentrations were elevated in rats fed diets adequate or deficient in vitamin B6 containing 2.4% L-cystine; however, plasma protein-bound cysteine was not increased. Feeding high cystine diets did not slow the accumulation or decrease the concentration of plasma protein-bound or free homocyst(e)ine in vitamin B6-deficient rats. An in vitro experiment demonstrated that plasma protein-bound cysteine increased when plasma was incubated with increasing concentrations of cysteine, and decreased with increasing homocysteine concentrations. Plasma protein-bound homocysteine concentration was increased by increasing the concentration of homocysteine in the incubation medium; however, increasing the cysteine concentration failed to decrease bound homocysteine. The affinity of homocysteine for binding sites on plasma proteins appeared to be high because cysteine did not displace the bound homocysteine. Therefore, feeding a high cystine diet is unlikely to cause a decrease in bound homocysteine in homocystinuric patients due to competition for binding sites, but may still be beneficial because plasma cystine concentrations are below normal in individuals with homocystinuria.


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
R. A. Ward
Protein-Leaking Membranes for Hemodialysis: A New Class of Membranes in Search of an Application?
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2421 - 2430.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. K. Majors, S. Sengupta, B. Willard, M. T. Kinter, R. E. Pyeritz, and D. W. Jacobsen
Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin
Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1354 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. H. Williams, J. A. Maggiore, R. D. Reynolds, and C. M. Helgason
Novel Approach for the Determination of the Redox Status of Homocysteine and Other Aminothiols in Plasma from Healthy Subjects and Patients with Ischemic Stroke
Clin. Chem., June 1, 2001; 47(6): 1031 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Mansoor, C. Bergmark, A. M. Svardal, P. E. Lonning, and P. M. Ueland
Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease
Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 232 - 240.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by The American Society for Nutrition